Amgen (AMG 337)

Business Data, Corporate Office and Headquarter Address

About

Amgen (AMG 337) is Buildings and Property in United States that focus on inhibitor drug business. They cover business area such as cancer cell scattering, invasion, protection, apoptosis, gastric and esophageal cancer.

Business Type

Buildings and Property

Country

United States

Founded

-

Company Focus

Inhibitor Drug

Website

-

Corporate Office and Headquarter Office address:

One Amgen Center Drive
Thousand Oaks, CA 91320
United States

Phone number:

Private

Office Opening Hours*:

Monday 9.30 - 17.00
Tuesday 9.30 - 17.00
Wednesday 9.30 - 17.00
Thursday 9.30 - 17.00
Friday 9.30 - 17.00
Saturday Closed
Sunday Closed

Business Coverage

cancer cell scatteringinvasionprotectionapoptosisgastric and esophageal cancer

* We use standard office opening hours in near Amgen (AMG 337)'s location as default value for unknown and outdated data. For more valid info, please verify the info from more trusted sources like GoogleMyBusiness, Yelp, FourSquare or similar services.

Amgen (AMG 337) Frequently Asked Questions

What or who is Amgen (AMG 337)?

Amgen (AMG 337) is Buildings and Property business from United States that founded in - ( years old in ), Amgen (AMG 337) business is focusing on Inhibitor Drug.

Where is Amgen (AMG 337) headquarter and corporate office address?

Amgen (AMG 337) headquarter office and corporate office address is located in One Amgen Center Drive Thousand Oaks, CA 91320 United States.

Where is Amgen (AMG 337) country origins?

Amgen (AMG 337) was founded in United States.

What is Inhibitor Drug business focus on?

In , Amgen (AMG 337) is currently focus on inhibitor drug sector.

Disclaimer: This website is not affiliated with Amgen (AMG 337), any government agency, does not create this data, vouch for its accuracy, or guarantee that it is the most recent data available. The data displayed is available through open government websites and public online directory. This website expressly disclaims the accuracy, adequacy, or completeness of any data and shall not be liable for any errors, omissions or other defects in, delays or interruptions in such data, or for any actions taken in reliance thereon.